Hervé de Kergrohen
Chief Executive Officer at MEDICAL DEVICE WORKS
Profile
Hervé de Kergrohen is currently the Chief Executive Officer at Medical Device Works NV and also holds the position of Director at AXS Medical SAS.
Previously, he served as the Chief Executive Officer at Anavex Life Sciences Corp.
from 2009 to 2010.
He has also held various director positions at Ontrak, Inc., Sandoz, Inc., Clearant, Inc., Xytis, Inc., G.D.
Searle & Co., Inc., Kuros Biosurgery Holding AG, genOway SA, Arbiom SAS, Praxim SA, and Xcorporeal, Inc. Additionally, he worked as the Head-Strategy at UBS AG from 1997 to 1998 and as an Analyst at Darier Hentsch & Cie in 2002.
Dr. de Kergrohen has an MBA from INSEAD and a doctorate from the University of Strasbourg.
Hervé de Kergrohen active positions
Companies | Position | Start |
---|---|---|
MEDICAL DEVICE WORKS | Chief Executive Officer | 2011-06-30 |
AXS Medical SAS
AXS Medical SAS Electronic Equipment/InstrumentsElectronic Technology Part of Diagnostic Medical Systems, AXS Medical SAS is a French company that designs, develops and markets medical devices. The company is based in Mérignac, France. AXS Medical was acquired by Diagnostic Medical Systems on July 08, 2015. | Director/Board Member | - |
Former positions of Hervé de Kergrohen
Companies | Position | End |
---|---|---|
IMMUNE PHARMACEUTICALS, INC. | Director/Board Member | 2013-10-14 |
ANAVEX LIFE SCIENCES CORP. | Chief Executive Officer | 2010-02-28 |
Innovation Capital SASU
Innovation Capital SASU Investment ManagersFinance Innovation Capital SASU (Innovation Capital) is the international venture capital subsidiary of CDC Capital Investissement SAS, itself a wholly-owned subsidiary of State-owned CDC Caisse des Dépôts et Consignations in France. Established in 1996 as CDC Entreprises Innovation, the firm was formerly known as CDC Innovation SASU. They changed their name to Innovation Capital SASU in 2012. Located in Paris with representative offices in California and in Switzerland, the firm manages venture capital and innovation mutual funds (FCPRs and FCPIs). Their venture capital funds are sponsored by CDC Capital Investissement, and the innovation funds are generally co-invested with the venture capital funds. The firm's mandate includes public interest missions. | Private Equity Investor | 2009-09-30 |
Clearant, Inc.
Clearant, Inc. Pharmaceuticals: MajorHealth Technology Clearant, Inc. produces tissue allograft implants, plasma therapies, blood and recombinant products. The company was founded on April 30, 1999 and is headquartered in Orlando, FL. | Director/Board Member | 2007-04-24 |
Darier Hentsch & Cie | Analyst-Equity | 2002-05-30 |
Training of Hervé de Kergrohen
INSEAD | Masters Business Admin |
University of Strasbourg | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 5 |
---|---|
ONTRAK, INC. | Health Services |
GENOWAY | Health Technology |
XCORPOREAL, INC. | Health Technology |
ANAVEX LIFE SCIENCES CORP. | Health Technology |
MEDICAL DEVICE WORKS | Health Technology |
Private companies | 12 |
---|---|
Clearant, Inc.
Clearant, Inc. Pharmaceuticals: MajorHealth Technology Clearant, Inc. produces tissue allograft implants, plasma therapies, blood and recombinant products. The company was founded on April 30, 1999 and is headquartered in Orlando, FL. | Health Technology |
Arbiom SAS
Arbiom SAS Pharmaceuticals: MajorHealth Technology Biométhodes SA develops a technology in engineering and optimization of enzymes. It offers chemical pretreatment of non-food biomass and bio-refinery process. The company was founded in 1997 and is headquartered in Evry, France. | Health Technology |
Kuros Biosurgery Holding AG
Kuros Biosurgery Holding AG Miscellaneous Commercial ServicesCommercial Services Kuros Biosurgery Holding AG operated as a medical technology company. It engaged in the development of biologic and biomaterial-based product candidates for localized therapy in trauma, spine and wound care. The company was founded by Marion Bavand, Didier Cowling, Dominik Ellenrieder, and Jeffrey Hubbel on April 3, 2008 and was headquartered in Zurich, Switzerland. | Commercial Services |
Praxim SA
Praxim SA Medical SpecialtiesHealth Technology Praxim SA manufactures and sells orthopedic surgical instruments. It specializes in minimal invasive products for knee arthroscopy. The company was founded by Stéphane Lavallée in 1995 and is headquartered in La Tronche, France. | Health Technology |
Sandoz, Inc.
Sandoz, Inc. Pharmaceuticals: MajorHealth Technology Sandoz, Inc. develops, manufactures and distributes generic pharmaceutical products. The firm focuses on therapeutic drug categories such as anti-infective, central nervous system disorder treatments, cardiovascular medicines, gastrointestinal agent, oncology therapies, and respiratory therapies. The company was founded in 1946 and is headquartered in Princeton, NJ. | Health Technology |
G.D. Searle & Co., Inc.
G.D. Searle & Co., Inc. Chemicals: SpecialtyProcess Industries G.D. Searle & Co., Inc. is a company that produces a diverse range of chemicals and agricultural products. The company is based in St. Louis, MO. G.D. Searle & Co. was acquired by Monsanto Co. /Old/ on January 01, 1985. | Process Industries |
UBS AG
UBS AG Investment ManagersFinance UBS AG engages in the provision of financial advisory solutions for private and institutional investors, intermediaries, and wealth management clients. The firm focuses on the areas of wealth and asset management, as well as investment banking. It offers retail investment products, global financing services, investment research, bespoke financing, traditional investments, as well as bonds and equities. The company was founded in 1862 and is headquartered in Zurich, Switzerland. | Finance |
Innovation Capital SASU
Innovation Capital SASU Investment ManagersFinance Innovation Capital SASU (Innovation Capital) is the international venture capital subsidiary of CDC Capital Investissement SAS, itself a wholly-owned subsidiary of State-owned CDC Caisse des Dépôts et Consignations in France. Established in 1996 as CDC Entreprises Innovation, the firm was formerly known as CDC Innovation SASU. They changed their name to Innovation Capital SASU in 2012. Located in Paris with representative offices in California and in Switzerland, the firm manages venture capital and innovation mutual funds (FCPRs and FCPIs). Their venture capital funds are sponsored by CDC Capital Investissement, and the innovation funds are generally co-invested with the venture capital funds. The firm's mandate includes public interest missions. | Finance |
Xytis, Inc.
Xytis, Inc. BiotechnologyHealth Technology Xytis, Inc. was engaged in the development of central nervous system. The company was founded by Werner Tschollar in January 2006 and was headquartered in Irvine, CA. | Health Technology |
Darier Hentsch & Cie | Finance |
Immune Pharmaceuticals, Inc.
Immune Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Immune Pharmaceuticals, Inc. is a biopharmaceutical company developing novel therapeutic agents for the treatment of immunologic and inflammatory diseases. Its lead product, Bertilimumab, is a human monoclonal antibody that binds eotaxin-1, a chemokine that attracts eosinophils to the site of inflammation. Bertilimumab has shown promising clinical activity in bullous pemphigoid and has been studied in other conditions including allergic rhinitis and ulcerative colitis, and may have application in other diseases, including atopic dermatitis, asthma, and other diseases. It is also developing NanoCyclo, a topical nano-encapsulated formulation of cyclosporine, for the treatment of atopic dermatitis (AD) and psoriasis. The company was founded by Daniel Gedeon Teper on March 9, 1993 and is headquartered in Englewood Cliffs, NJ. | Health Technology |
AXS Medical SAS
AXS Medical SAS Electronic Equipment/InstrumentsElectronic Technology Part of Diagnostic Medical Systems, AXS Medical SAS is a French company that designs, develops and markets medical devices. The company is based in Mérignac, France. AXS Medical was acquired by Diagnostic Medical Systems on July 08, 2015. | Electronic Technology |
- Stock Market
- Insiders
- Hervé de Kergrohen